Filtered By:
Source: Atherosclerosis
Condition: Heart Failure
Education: Study
This page shows you your search results in order of relevance. This is page number 6.
Order by Relevance | Date
Total 147 results found since Jan 2013.
Midlife determinants of healthy cardiovascular aging: The Atherosclerosis Risk in Communities (ARIC) study
CONCLUSIONS: More-stringent levels of modifiable risk factors in midlife beyond current clinical practice and guidelines were associated with preserved cardiovascular health in older age.PMID:35550933 | DOI:10.1016/j.atherosclerosis.2022.04.028
Source: Atherosclerosis - May 13, 2022 Category: Cardiology Authors: Xiaoming Jia Caroline Sun Vijay Nambi Salim S Virani George Taffet Eric Boerwinkle Jan Bressler Chiadi Ndumele B Gwen Windham James A de Lemos Kunihiro Matsushita John William McEvoy Ron C Hoogeveen Elizabeth Selvin Christie M Ballantyne Source Type: research
N6-Methyladenosine RNA Methylation in Cardiovascular Diseases
Front Cardiovasc Med. 2022 Apr 29;9:887838. doi: 10.3389/fcvm.2022.887838. eCollection 2022.ABSTRACTN6-methyladenosine (m6A) modification is the most universal and abundant post-transcriptional modification of eukaryotic RNA and occurs mainly at the consensus motif RR (m6A) CH (R = A or G, H = A, C, or U) in long internal exons, near stop codons, or in the 3' untranslated region (UTR). "Writers," "erasers," and "readers" are responsible for the occurrence, removal, and recognition of m6A modification, respectively. Substantial evidence has shown that m6A RNA modification can exert important functions in physiological and p...
Source: Atherosclerosis - May 16, 2022 Category: Cardiology Authors: Chi Liu Lei Gu Wenjuan Deng Qianchao Meng Nan Li Guifeng Dai Suli Yu Hong Fang Source Type: research
Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities Study
CONCLUSIONS: Renin suppression and aldosterone excess, consistent with primary aldosteronism pathophysiology, were associated with cardiac structural and functional alterations and may represent an early target for mitigation of fibrosis with mineralocorticoid receptor antagonists.PMID:35582954 | DOI:10.1161/HYPERTENSIONAHA.122.19134
Source: Atherosclerosis - May 18, 2022 Category: Cardiology Authors: Jenifer M Brown Magnus O Wijkman Brian L Claggett Amil M Shah Christie M Ballantyne Josef Coresh Morgan E Grams Zhiying Wang Bing Yu Eric Boerwinkle Anand Vaidya Scott D Solomon Source Type: research
Lipoprotein(a) and cardiovascular and valvular diseases: A genetic epidemiological perspective
We present Lp(a) threshold values that may be clinically relevant and identify other cardiovascular risk factors that may modulate the absolute risk of CVD in individuals with high Lp(a) levels. Finally, we identify key clinical and research questions that require further investigation to eventually and optimally reduce CVD risk in patients with high Lp(a) levels.PMID:35606078 | DOI:10.1016/j.atherosclerosis.2022.04.015
Source: Atherosclerosis - May 23, 2022 Category: Cardiology Authors: Benoit J Arsenault Pia R Kamstrup Source Type: research
A Randomized Controlled Trial Evaluating Outcome Impact of Cilostazol in Patients with Coronary Artery Disease or at a High Risk of Cardiovascular Disease
In conclusion, these results suggest cilostazol may have beneficial effects in patients with CAD or at a high risk of CV disease.PMID:35743723 | DOI:10.3390/jpm12060938
Source: Atherosclerosis - June 24, 2022 Category: Cardiology Authors: Jia-Ling Lin Wei-Kung Tseng Po-Tseng Lee Cheng-Han Lee Shih-Ya Tseng Po-Wei Chen Hsien-Yuan Chang Ting-Hsing Chao Source Type: research
Risk Factors for Major Adverse Cardiovascular Events and Major Adverse Limb Events after Venous Thromboembolism: A Large Prospective Cohort Study
CONCLUSIONS: Risk factors for MACE and MALE after VTE included some traditional cardiovascular risk factors, patient's comorbidities, and some characteristics of VTE.PMID:35772402 | DOI:10.1055/s-0042-1748152
Source: Atherosclerosis - June 30, 2022 Category: Cardiology Authors: Steve Raoul Noumegni Romain Didier Vincent Mansourati Emmanuelle Le Moigne Raphael Le Mao Cl ément Hoffmann Claire De Moreuil C écile Tromeur Pierre-Yves Le Roux Bahaa Nasr Jean-Christophe Gentric Marie Guegan Elise Poulhazan Karine Lacut Luc Bressollet Source Type: research
The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation
Front Cell Infect Microbiol. 2022 Jun 20;12:903570. doi: 10.3389/fcimb.2022.903570. eCollection 2022.ABSTRACTIn the last two decades, considerable interest has been shown in understanding the development of the gut microbiota and its internal and external effects on the intestine, as well as the risk factors for cardiovascular diseases (CVDs) such as metabolic syndrome. The intestinal microbiota plays a pivotal role in human health and disease. Recent studies revealed that the gut microbiota can affect the host body. CVDs are a leading cause of morbidity and mortality, and patients favor death over chronic kidney disease. ...
Source: Atherosclerosis - July 7, 2022 Category: Cardiology Authors: Md Mominur Rahman Fahadul Islam Md Harun -Or-Rashid Abdullah Al Mamun Md Saidur Rahaman Md Mohaimenul Islam Atkia Farzana Khan Meem Popy Rani Sutradhar Saikat Mitra Anjuman Ara Mimi Talha Bin Emran None Fatimawali Rinaldi Idroes Trina Ekawati Tallei Munir Source Type: research
What Is or What Is Not a Risk Factor for Arterial Hypertension? Not Hamlet, but Medical Students Answer That Question
Int J Environ Res Public Health. 2022 Jul 5;19(13):8206. doi: 10.3390/ijerph19138206.ABSTRACTHypertension is a leading cause of cardiovascular disease and premature death worldwide. The most important method of preventing hypertension is social awareness of its causes. An important role in educating society about hypertension is played by medical personnel. The study involved 327 students of medicine representing all years of study. The study used a proprietary questionnaire containing test questions about knowledge of the causes of hypertension (classical and non-classical factors), as well as questionable and false risk ...
Source: Atherosclerosis - July 9, 2022 Category: Cardiology Authors: Tomasz Sobierajski Stanis ław Surma Monika Roma ńczyk Krzysztof Łabuzek Krzysztof J Filipiak Suzanne Oparil Source Type: research
Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age: The Copenhagen General Population Study
CONCLUSIONS: Lipoprotein(a) levels increased modestly around age 50 selectively in women; however, risk of morbidity and mortality for high lipoprotein(a) was similar in women and men above age 50. This implies that elevated lipoprotein(a) above age 50 is a relatively more common cardiovascular risk factor in women, pointing toward repeat measurements in women above age 50.PMID:35803767 | DOI:10.1016/j.atherosclerosis.2022.06.1023
Source: Atherosclerosis - July 8, 2022 Category: Cardiology Authors: Sofie Bay Simony Martin B ødtker Mortensen Anne Langsted Shoaib Afzal Pia R ørbæk Kamstrup B ørge Grønne Nordestgaard Source Type: research
Early statin use and cardiovascular outcomes after myocardial infarction: A population-based case-control study
CONCLUSIONS: Lack of statin therapy early after MI is associated with adverse outcomes across the spectrum of MI patients. Results underline the importance of timely statin use after MI.PMID:35803064 | DOI:10.1016/j.atherosclerosis.2022.06.1019
Source: Atherosclerosis - July 8, 2022 Category: Cardiology Authors: Ville Kyt ö Antti Saraste Aleksi Tornio Source Type: research
What Is or What Is Not a Risk Factor for Arterial Hypertension? Not Hamlet, but Medical Students Answer That Question
Int J Environ Res Public Health. 2022 Jul 5;19(13):8206. doi: 10.3390/ijerph19138206.ABSTRACTHypertension is a leading cause of cardiovascular disease and premature death worldwide. The most important method of preventing hypertension is social awareness of its causes. An important role in educating society about hypertension is played by medical personnel. The study involved 327 students of medicine representing all years of study. The study used a proprietary questionnaire containing test questions about knowledge of the causes of hypertension (classical and non-classical factors), as well as questionable and false risk ...
Source: Atherosclerosis - July 9, 2022 Category: Cardiology Authors: Tomasz Sobierajski Stanis ław Surma Monika Roma ńczyk Krzysztof Łabuzek Krzysztof J Filipiak Suzanne Oparil Source Type: research
